Change over period: —
NSE · EXCELINDUS
EXCEL INDUST
-10.7% from the 52-week high · +25.5% above the low
Excel Industries Ltd. engages in the manufacture and sale of chemicals, pharma intermediates and environmental products. The company is headquartered in Mumbai, Maharashtra. The firm is engaged in the manufacturing and selling of chemicals, pharma intermediates and environmental products. Its Chemicals segment consists of industrial and specialty chemicals, pesticide intermediates, polymer and pharma intermediates. Its Environment and Biotech segment includes soil enricher, bio-pesticides and other bio-products. The company is also engaged in manufacturing activity on behalf of third parties. Its product portfolio includes agro chemical intermediates, specialty chemicals, polymer inputs and active pharma ingredients (APIs). Its agro chemical products are used as intermediates in the manufacturing of various insecticides and herbicides. Its specialty chemicals include phosphonates, biocides and mining chemicals. Its polymer inputs are used as cross-linking or branching agents for polymers. Its APIs are used in anti-diabetic and anti-gout therapeutic applications.
The short version. EXCEL INDUST reported revenue of ₹275 crore for Sep 2026, up 1.9% from a year earlier. Net profit was ₹29 crore (up 38.1% year on year). Return on equity was 4.4% in Mar 2026. Promoter holding was 51.86% in Sep 2026, down 0.70 points over 8 quarters.
1 · The price
How has the stock traded?
EXCEL INDUST trades 10.7% below its 52-week high and 25.5% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹275 cr.
Sep 2026 net profit of ₹29 cr.
2.7 pts higher than a year earlier.
Revenue compounded at 0.6% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 275 | 294 | 281 | 234 | 270 | 310 | 248 | 196 |
| Net profit | 29 | 29 | 12 | 8 | 21 | 34 | 12 | 6 |
| Net margin % | 10.5 | 10.0 | 4.4 | 3.6 | 7.8 | 10.9 | 5.0 | 3.2 |
| EPS (₹) | 22.99 | 23.44 | 9.77 | 6.71 | 16.86 | 26.85 | 9.87 | 4.93 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1095 | 978 | 826 | 1090 | 1178 | 749 | 702 | 825 |
| Net profit | 76 | 85 | 17 | 80 | 161 | 71 | 96 | 153 |
| Net margin % | 6.9 | 8.7 | 2.1 | 7.3 | 13.7 | 9.5 | 13.7 | 18.6 |
| EPS (₹) | 60.19 | 67.87 | 13.53 | 63.59 | 128.24 | 56.55 | 76.43 | 122.07 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 4.4% in Mar 2026; debt to equity is 0.00.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 4.4 | 5.4 | 1.2 | 6.4 |
| Return on capital % | 5.3 | 6.6 | 1.5 | 7.9 |
| EBITDA margin % | 12.2 | 14.9 | 6.5 | 12.6 |
| Net margin % | 6.7 | 8.5 | 2.0 | 7.2 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 0.6% | 8.1% |
| Profit CAGR | -1.8% | 1.3% |
4 · The owners
Who holds it, and are they adding?
Down 0.7 pts over 8 quarters.
Down 0.51 pts over 8 quarters.
Up 0.02 pts over 8 quarters.
+0 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 52.56 | 52.65 | 52.67 | 52.67 | 52.69 | 52.69 | 51.86 | 51.86 | -0.7 |
| FII | 2.18 | 2.05 | 2.08 | 2.01 | 2.01 | 1.94 | 1.86 | 1.67 | -0.51 |
| DII | 6.99 | 6.97 | 6.97 | 7.05 | 7.06 | 7.07 | 7.07 | 7.01 | +0.02 |
| Public | 38.27 | 38.32 | 38.27 | 38.26 | 38.24 | 38.3 | 39.22 | 39.47 | +1.2 |
Mutual fund holdings · Oct 2026
0 schemes hold this stock
0 the month before.
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for EXCEL INDUST are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Chemicals & Petrochemicals stocks
Quick answers
Common questions about EXCEL INDUST
What is the EXCEL INDUST share price?
EXCEL INDUST (EXCELINDUS) last closed at ₹1,009.60, down 0.27% on the day. Its 52-week range is ₹806.40 to ₹1,133.25.
What is the market cap of EXCEL INDUST?
EXCEL INDUST has a market capitalisation of about ₹1,272 crore. Its price-to-earnings ratio is 16.3.
How are EXCEL INDUST's latest results?
EXCEL INDUST reported revenue of ₹275 crore for Sep 2026, up 1.9% from a year earlier. Net profit was ₹29 crore (up 38.1% year on year). Return on equity was 4.4% in Mar 2026. Promoter holding was 51.86% in Sep 2026, down 0.70 points over 8 quarters.
Who owns EXCEL INDUST?
As of Sep 2026, shareholding was: Promoter 51.86%, FII 1.67%, DII 7.01%, Public 39.47%.
How many mutual funds hold EXCEL INDUST?
0 mutual fund schemes held EXCEL INDUST in October 2026. That compares with 0 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 14 Aug 2025 · Final Dividend - Rs. 13.75
- 12 Sep 2024 · Final Dividend - Rs. 5.5
- 07 Sep 2023 · Final Dividend - Rs. 11.25
- 15 Sep 2022 · Final Dividend - Rs. 22.5
- 16 Sep 2021 · Final Dividend - Rs. 11.25
- 19 Mar 2020 · Interim Dividend - Rs. 10
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.